Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pfeffer

Showing results (741-750 of 754) with videos related to

Pageof 76
Sort By:
Journal of the American Heart Association|June 21, 2024
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic SubstudyNatasha L Patel-Murray, Luqing Zhang, Brian L Claggett, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
European Journal of Heart Failure|December 17, 2021
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fractionAlice M Jackson, Rasmus Rørth, Jiankang Liu, et al.
The New England Journal of Medicine|September 3, 2019
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionScott D Solomon, John J V McMurray, Inder S Anand, et al.
European Journal of Heart Failure|March 28, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessmentMartin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, et al.
Circulation|February 28, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.
Journal of the American College of Cardiology|March 3, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.
Lancet (London, England)|June 24, 2019
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling studyKatherine E Battle, Tim C D Lucas, Michele Nguyen, et al.
Lancet (London, England)|June 24, 2019
Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000-17: a spatial and temporal modelling studyDaniel J Weiss, Tim C D Lucas, Michele Nguyen, et al.
Science (New York, N.Y.)|July 16, 2016
Gradual caldera collapse at Bárdarbunga volcano, Iceland, regulated by lateral magma outflowMagnús T Gudmundsson, Kristín Jónsdóttir, Andrew Hooper, et al.
Pageof 76

Showing results (741-750 of 754) with videos related to

Sort By:
Pageof 76
Journal of the American Heart Association|June 21, 2024
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic SubstudyNatasha L Patel-Murray, Luqing Zhang, Brian L Claggett, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
European Journal of Heart Failure|December 17, 2021
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fractionAlice M Jackson, Rasmus Rørth, Jiankang Liu, et al.
The New England Journal of Medicine|September 3, 2019
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionScott D Solomon, John J V McMurray, Inder S Anand, et al.
European Journal of Heart Failure|March 28, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessmentMartin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, et al.
Circulation|February 28, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.
Journal of the American College of Cardiology|March 3, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.
Lancet (London, England)|June 24, 2019
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling studyKatherine E Battle, Tim C D Lucas, Michele Nguyen, et al.
Lancet (London, England)|June 24, 2019
Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000-17: a spatial and temporal modelling studyDaniel J Weiss, Tim C D Lucas, Michele Nguyen, et al.
Science (New York, N.Y.)|July 16, 2016
Gradual caldera collapse at Bárdarbunga volcano, Iceland, regulated by lateral magma outflowMagnús T Gudmundsson, Kristín Jónsdóttir, Andrew Hooper, et al.
Pageof 76